as 05-09-2025 4:00pm EST
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Founded: | 1910 | Country: | United States |
Employees: | N/A | City: | IRVING |
Market Cap: | 43.4B | IPO Year: | N/A |
Target Price: | $145.08 | AVG Volume (30 days): | 2.4M |
Analyst Decision: | Hold | Number of Analysts: | 12 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 7.34 | EPS Growth: | 34.72 |
52 Week Low/High: | $124.10 - $150.45 | Next Earning Date: | 04-22-2025 |
Revenue: | $19,749,000,000 | Revenue Growth: | -3.12% |
Revenue Growth (this year): | -1.73% | Revenue Growth (next year): | 2.32% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Chen Katy | KMB | President, Int'l Personal Care | May 1 '25 | Sell | $129.70 | 740 | $95,978.00 | 3,997 | |
Chen Katy | KMB | President, Int'l Personal Care | Apr 26 '25 | Sell | $130.74 | 1,794 | $234,544.87 | 3,997 | |
Drexler Andrew | KMB | Vice President and Controller | Feb 21 '25 | Sell | $140.00 | 2,500 | $350,000.00 | 2,553 |
KMB Breaking Stock News: Dive into KMB Ticker-Specific Updates for Smart Investing
PR Newswire
3 days ago
Simply Wall St.
3 days ago
MT Newswires
3 days ago
PR Newswire
3 days ago
Manufacturing.NET
7 days ago
TipRanks
7 days ago
TipRanks
7 days ago
Simply Wall St.
7 days ago
The information presented on this page, "KMB Kimberly-Clark Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.